CAS: 62-75-9; N,N-Dimethylnitrous Amide

上下游产品

N,N-dimethylammonium chloride ethanol 4,5-dimethyl-1,2-dinitrobenzene dimethyl amineN,N-dimethylhydrazine hydr°Chloride dimethyl amine N,N-Dimethylhydrazine 1,4-dimethyl-2,5-diphenyl-[1,2,4,5]tetrazinanepyridine ethanol tetranitromethane benzhydrylidene(methyl)amine1,1'-diethyl-2,2'-diphenyl-[3,3']azoindole 9-phenyl-6,7,8,9-tetrahydro-5H-carbazole azophenin 1,3-Diphenyltriazen

📜西酞普兰置于sodium Hypochlorite体系中,用 Aq. Phosphate Buffer 作为反应溶剂,化学反应 240.0H,反应生成 亚硝基二甲胺
参考文献:用次氯酸钠和二氧化氯氧化西酞普兰:影响因素和 Ndma 形成动力学
标题:用次氯酸钠和二氧化氯氧化西酞普兰:影响因素和 Ndma 形成动力学
摘要:高度处方的抗抑郁药西酞普兰作为一种新兴的污染物,经常在水生环境中被检测到.在次氯酸钠 (Naocl) 和二氧化氯 (Clo2) 氯化过程中检查了西酞普兰氧化,因为传统的废水处理厂无法有效去除西酞普兰.在我们之前的研究中,西酞普兰已被证明在氯化过程中会形成 N-亚硝基二甲胺 (Ndma).本研究对 Ndma 形成动力学进行了进一步研究.评估了操作变量(消毒剂剂量,Ph 值)和水基质对西酞普兰降解以及 Ndma 反应生成的影响.结果表明西酞普兰与 Naocl 和 Clo2 具有高反应性.ndma 的形成包括 Cit 氧化过程中的两个阶段,与反应时间呈线性关系.naocl 更有利于去除 Cit,但会导致更多的 Ndma 形成.增加消毒剂剂量促进了西酞普兰的去除和 Ndma 的形成.然而,在西酞普兰去除和 Ph 值之间没有发现一致的相关性.与去除西酞普兰的情况相反,当西酞普兰存在于实际水基质中时,Ndma
DOI:10.3390/molecules24173065

专利信息

专利号:WO-2024057083-A1
优先权日:2022-11-28
标 题 :Process for the synthesis of selectively alkylated cyclodextrins
发明人：IVÃ?NYI RÓBERT; TUZA KATA; SZENTE LAJOS; PUSKÃ?S ISTVÃ?N; SZÅ?CS LEVENTE; KURKAYEV ABDULA
权利人:CYCLOLAB CYCLODEXTRIN R&D LABORATORY LTD
摘要:The present invention generally relates to a process for the synthesis of selectively alkylated cyclodextrins. More particularly, the present invention relates to a process of cyclodextrin alkylation in a selective manner yielding hexakis(2,6-di-O-alkyl)-alpha-cyclodextrin, heptakis(2,6-di-O-alkyl)-beta-cyclodextrin and octakis(2,6-di-O-alkyl)-gamma-cyclodextrin.

专利号:US-12215369-B2
优先权日:2019-03-01
标题:Method for the in vivo synthesis of 4-hydroxymethylfurfural and derivatives thereof
发明人：ALEXANDRINO PAULO MOISES RADUAN; GOUVEA IURI ESTRADA; QUEIROZ VERONICA LEITE
权利人:BRASKEM SA
摘要:The present disclosure provides recombinant microorganisms and methods for the production of 4-HMF, 2,4-furandimethanol, furan-2,4-dicarbaldehyde, 4-(hydroxymethyl)furoic acid, 2-formylfuran-4-carboxylate, 4-formylfuran-2-carboxylate, and/or 2,4-FDCA from a carbon source. The method provides for engineered microorganisms that express endogenous and/or exogenous nucleic acid molecules that catalyze the conversion of a carbon source into 4-HMF, 2,4-furandimethanol, furan-2,4-dicarbaldehyde, 4-(hydroxymethyl)furoic acid, 2-formylfuran-4-carboxylate, 4-formylfuran-2-carboxylate, and/or 2,4-FDCA. The disclosure further provides methods of producing polymers derived from 4-HMF, 2,4-furandimethanol, furan-2,4-dicarbaldehyde, 4-(hydroxymethyl)furoic acid, 2-formylfuran-4-carboxylate, 4-formylfuran-2-carboxylate, and/or 2,4-FDCA.

专利号:US-12291505-B2
优先权日:2016-07-04
标题 :Methods for the synthesis of deuterated dextromethorphan
发明人：JOHNSON MATT; ZHAO CUNXIANG; MENG WEIHUA; LU ZHIJUN; LI YAN
权利人:AVANIR PHARMACEUTICALS INC
摘要:The application describes methods for making a deuterated dextromethorphan of Formula (I), deuterated dextromethorphan produced by these methods, and pharmaceutically acceptable salts thereof.

专利号:US-2013200009-A1
优先权日:2011-07-08
标题 :Method for Synthesis of MultiFunctional FE6+ - FE3+ Agent
发明人：FAN MAOHONG
权利人:FAN MAOHONG; UNIV WYOMING
摘要:The present invention is a new, easy method for preparing stable solid Fe 6+ —Fe 3+ agents in a fixed bed reactor by using O 3 and FeOOH along with KOH with conversion efficiencies of approximately 27%. In addition, the product has been used to oxidize oil from water and to destroy tetracycline in water

专利号:US-5955633-A
优先权日:1997-03-20
标题 :Synthesis of tertiary amine oxides
发明人：PRABHU VAIKUNTH S
权利人:GEN ELECTRIC
摘要:A process is provided for the manufacture of free-flowing solid tertiary amine oxides having N-nitrosodimethylamine levels of less than about 250 ppb. The process comprises heating a mixture of a tertiary amine, a polar hydroxy alkyl solvent, an organic acid, and aqueous hydrogen peroxide, followed by removal of the solvent and water, preferably by azeotropic removal. The resultant tertiary amine oxides have good color without bleaching and are useful without further purification.

专利号:WO-2023046836-A1
优先权日:2021-09-24
标 题:Process for preparing sartans
发明人：ZUPANCIC SILVO; SENICAR TANJA; PERÅ E BOÅ TJAN; BOMBEK SERGEJA; KLOBCAR ANDREJ; KRAÅ OVEC DuÅ¡an
权利人:KRKA D D NOVO MESTO
摘要:The present application relates to a process for purifying a tetrazole-containing-sartan or a tetrazole-containing-sartan intermediate, the process comprising the steps of (a) providing a composition comprising an azide-impurity together with a tetrazole-containing-sartan or with an intermediate of a tetrazole-containing-sartan; (b) treating the composition provided in step (a) with a reducing agent; preferably reacting the azide-impurity with a reducing agent thereby obtaining an amine-impurity; and (c) optionally, isolating the tetrazole-containing-sartan or the intermediate of the tetrazole-containing-sartan from the composition. The application further relates to a process for the synthesis of tetrazole-containing-sartans which ensures azide-impurities free final active pharmaceutical ingredients as well as azide-impurities free intermediates of tetrazole-containing-sartans that are suitable for the subsequent synthesis of tetrazole-containing-sartans.